Text Size

Functional Neuroimaging of Cortical Plasticity in the Human Visual System

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2010 by Baylor College of Medicine.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
The Dana Foundation
Plasticise Consortium
Max Planck Institute for Biological Cybernetics
Information provided by:
Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT01062672
First received: February 3, 2010
Last updated: December 21, 2010
Last verified: December 2010
History of Changes
  Purpose

The study's objective is to measure changes in human visual cortex organization that may arise as a result of injury to the visual pathways. Subjects with retinal or cortical injury will be studied and compared to appropriate controls. Functional magnetic resonance imaging methods are used to monitor cortical topography in time. The main aims of the study are to determine: 1) what are the patterns of cortical reorganization that are seen spontaneously after injury, and 2) whether rehabilitative training can promote adaptive reorganization enhancing recovery.


Condition
Stroke
Blindness
Vision

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Functional Neuroimaging of Cortical Plasticity in the Human Visual System

Resource links provided by NLM:

MedlinePlus related topics: Rehabilitation
U.S. FDA Resources

Further study details as provided by Baylor College of Medicine:

Estimated Enrollment: 200
Study Start Date: January 2009
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients with lesions of the visual pathway (cortical or retinal)

Criteria

Inclusion Criteria:

  • Stable lesion of the visual pathways resulting in a visual field scotoma.

Exclusion Criteria:

  • Inability to undergo magnetic resonance imaging,
  • Inability to comply with basic instructions,
  • Inability to perform the behavioral tasks required,
  • Patients with chronic progressive neurological or psychiatric disorders,
  • Patients that are pregnant, or breast feeding.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01062672

Contacts
Contact: Stelios M Smirnakis, MD, PhD 713-798-3972 ssmirnakis@cns.bcm.edu

Locations
United States, Texas
Baylor College of Medicine Recruiting
Houston, Texas, United States, 77030
Contact: Stelios M Smirnakis, MD, PhD     713-798-3972     ssmirnakis@cns.bcm.edu    
Principal Investigator: Stelios M Smirnakis, MD, PhD            
Germany
Max Planck Institute for Biological Cybernetics Recruiting
Tuebingen, Germany
Contact: Stelios M Smirnakis, MD, PhD     713-798-3972     ssmirnakis@cns.bcm.edu    
Contact: Elke Krapp     ++4970712980726     elke.krapp@med.uni-tuebingen.de    
Principal Investigator: Ulrich Schiefer, MD            
Sponsors and Collaborators
Baylor College of Medicine
The Dana Foundation
Plasticise Consortium
Max Planck Institute for Biological Cybernetics
  More Information

No publications provided

Responsible Party: Stelios M. Smirnakis, Asst. Prof. of Neuroscience and Neurology, Baylor College of Medicine
ClinicalTrials.gov Identifier: NCT01062672     History of Changes
Other Study ID Numbers: H--22516
Study First Received: February 3, 2010
Last Updated: December 21, 2010
Health Authority: United States: Institutional Review Board
Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Baylor College of Medicine:
plasticity
reorganization
cortical
fMRI
rehabilitation

Additional relevant MeSH terms:
Blindness
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
 Cardiovascular Diseases
Vision Disorders
Sensation Disorders
Neurologic Manifestations
Eye Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on May 23, 2013